Generation of canine dendritic cells from peripheral blood monocytes without using purified cytokines

Veterinary Immunology and Immunopathology

Volumn 114, Issue 1-2, 2006, Pages 37-48

  Wijewardana, Viskam ^a   Sugiura, Kikuya ^a   Oichi, Tomoko ^a   Fujimoto, Mariko ^a   Akazawa, Takashi ^b   Hatoya, Shingo ^a   Inaba, Muneo ^c   Ikehara, Susumu ^c   Jayaweera, Thotawaththege S P ^d   Inaba, Toshio ^a  

^a Osaka Prefecture University   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d SABARAGAMUWA UNIVERSITY OF SRI LANKA   (Sri Lanka)

Author keywords

Dendritic cells; Dog; Monocytes; T cell conditioned medium

Indexed keywords

CD1 ANTIGEN; CD3 ANTIBODY; CYTOKINE; DENDRITIC CELL VACCINE; GAMMA INTERFERON; INTERLEUKIN 18; POLYINOSINIC POLYCYTIDYLIC ACID; T6 ANTIGEN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CULTURE MEDIUM; DENDRITIC CELL; DOG; FEMALE; IMMUNOSTIMULATION; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CULTURE MEDIA, CONDITIONED; CYTOKINES; DENDRITIC CELLS; DOGS; ENDOCYTOSIS; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE CULTURE TEST, MIXED; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; T-LYMPHOCYTES;

ANIMALIA; CANIS FAMILIARIS;

EID: 33748780643     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.07.002     Document Type: Article

References (49)

1. + monocytes to generate dendritic cells for cancer immunotherapy: a phase I study. J. Hematother. Stem Cell Res. 12 (2003) 515-523
2. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
3. Bienzle D., Reggeti F., Clark M.E., and Chow C. Immunophenotype and functional properties of feline dendritic cells derived from blood and bone marrow. Vet. Immunol. Immunopathol. 96 (2003) 19-30
4. Bonnefont-Rebeix C., de Carvalho C.M., Bernaud J., Chabanne L., Marchal T., and Rigal D. CD86 molecule is a specific marker for canine monocyte-derived dendritic cells. Vet. Immunol. Immunopathol. 109 (2006) 167-176
5. Boutemmine D., Bouchard N., Boerboom D., Jones H.E., Goff A.K., Dore M., and Sirois J. Molecular characterization of canine prostaglandin G/H synthase-2 and regulation in prostatic adenocarcinoma cells in vitro. Endocrinology 143 (2002) 1134-1143
6. Brand C.U., Hunger R.E., Yawalkar N., Gerber H.A., Schaffner T., and Braathen L.R. Characterization of human skin-derived CD1a-positive lymph cells. Arch. Dermatol. Res. 291 (1999) 65-72
7. Carrasco C.P., Rigden R.C., Schaffner R., Gerber H., Neuhaus V., Inumaru S., Takamatsu H., Bertoni G., McCullough K.C., and Summerfield A. Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties. Immunology 104 (2001) 175-184
8. Caruso D.A., Orme L.M., Neale A.M., Radcliff F.J., Amor G.M., Maixner W., Downie P., Hassall T.E., Tang M.L., and Ashley D.M. Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer. Neuro-Oncology 6 (2004) 236-246
9. Catchpole B., Stell A.J., and Dobson J.M. Generation of blood-derived dendritic cells in dogs with oral malignant melanoma. J. Comp. Pathol. 126 (2002) 238-241
10. + monocytes for anti-tumor immunotherapy. Leuk. Lymphoma 45 (2004) 1419-1428
11. Fernandez P.B., Lucibello F.C., Zuzarte M., Lutjens P., Muller R., and Havemann K. Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells. Eur. J. Cell Biol. 80 (2001) 99-110
12. Galkowska H., Waldemar L.O., and Wojewodzka U. Reactivity of antibodies directed against human antigens with surface markers on canine leukocytes. Vet. Immunol. Immunopathol. 53 (1996) 329-334
13. Goodell E.M., Blumenstock D.A., and Bowers W.E. Canine dendritic cells from peripheral blood and lymph nodes. Vet. Immunol. Immunopathol. 8 (1985) 301-310
14. + bone marrow progenitor cells. Transplantation 70 (2000) 1437-1442
15. Hatoya S., Torii R., Kumagai D., Sugiura K., Kawate N., Tamada H., Sawada T., and Inaba T. Expression of estrogen receptor alpha and beta genes in the mediobasal hypothalamus, pituitary and ovary during the canine estrous cycle. Neurosci. Lett. 347 (2003) 131-135
16. Helfand S.C., Hank J.A., Gan J., and Sondel P.M. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies. Cell Immunol. 167 (1996) 99-107
17. Ho C.S., Munster D., Pyke C.M., Hart D.N., and Lopez J.A. Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines. Blood 99 (2002) 2897-2904
18. Hogge G.S., Burkholder J.K., Culp J., Albertini M.R., Dubielzig R.R., Yang N.S., and MacEwen E.G. Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs. Cancer Gene Ther. 6 (1999) 26-36
19. Ibisch C., Pradal G., Bach J.M., and Lieubeau B. Functional canine dendritic cells can be generated in vitro from peripheral blood mononuclear cells and contain a cytoplasmic ultrastructural marker. J. Immunol. Methods 298 (2005) 175-182
20. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., and Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 (1992) 1693-1702
21. Jacobsen C.N., Aasted B., Broe M.K., and Petersen J.L. Reactivities of 20 anti-human monoclonal antibodies with leucocytes from ten different animal species. Vet. Immunol. Immunopathol. 39 (1993) 461-466
22. Kato K., Takaue Y., and Wakasugi H. T cell-conditioned medium efficiently induces the maturation and function of human dendritic cells. J. Leukoc. Biol. 70 (2001) 941-949
23. Lee J.J., Hughes C.S., Fine R.L., and Page R.L. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance. Cancer 77 (1996) 1892-1898
24. Leslie D.S., Vincent M.S., Spada F.M., Das H., Sugita M., Morita C.T., and Brenner M.B. CD1-mediated gamma/delta T cell maturation of dendritic cells. J. Exp. Med. 196 (2002) 1575-1584
25. Lipscomb M.F., and Masten B.J. Dendritic cells: immune regulators in health and disease. Physiol. Rev. 82 (2002) 97-130
26. Mahnke K., Becher E., Ricciardi-Castagnoli P., Luger T.A., Schwarz T., and Grabbe S. CD14 is expressed by subsets of murine dendritic cells and upregulated by lipopolysaccharide. Adv. Exp. Med. Biol. 417 (1997) 145-159
27. Mohamadzadeh M., and Luftig R. Dendritic cells: in the forefront of immunopathogenesis and vaccine development-a review. J. Immune Based Ther. Vaccines 2 (2004) 1
28. Morelli A.E., Zahorchak A.F., Larregina A.T., Colvin B.L., Logar A.J., Takayama T., Falo L.D., and Thomson A.W. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood 98 (2001) 1512-1523
29. Nat R., Radu E., Regalia T., and Popescu L.M. Apoptosis in the immune system: 1. Fas-induced apoptosis in monocytes-derived human dendritic cells. J. Cell. Mol. Med. 6 (2002) 223-234
30. Nelson E.L., Strobl S., Subleski J., Prieto D., Kopp W.C., and Nelson P.J. Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation. FASEB J. 13 (1999) 2021-2030
31. Paillot R., Laval F., Audonnet J.C., Andreon C., and Juillard V. Functional and phenotypic characterization of distinct porcine dendritic cells derived from peripheral blood monocytes. Immunology 102 (2001) 396-404
32. Pierre P., Turley S.J., Gatti E., Hull M., Meltzer J., Mirza A., Inaba K., Steinman R.M., and Mellman I. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388 (1997) 787-792
33. Randolph G.J., Inaba K., Robbiani D.F., Steinman R.M., and Muller W.A. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11 (1999) 753-761
34. Reddy A., Sapp M., Feldman M., Subklewe M., and Bhardwaj N. A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood 90 (1997) 3640-3646
35. Romani N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D., and Schuler G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 96 (1996) 137-151
36. Rozen S., and Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology (2000), Humana Press, Totowa, NJ 365-386
37. Ruppert J., Schutt C., Ostermeier D., and Peters J.H. Down-regulation and release of CD14 on human monocytes by IL-4 depends on the presence of serum or GM-CSF. Adv. Exp. Med. Biol. 329 (1993) 281-286
38. Sallusto F., Cella M., Danieli C., and Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182 (1995) 389-400
39. Scheinecker C., Machold K.P., Majdic O., Hocker P., Knapp W., and Smolen J.S. Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells. J. Immunol. 161 (1998) 3966-3973
40. Sporri R., and Reis e Sousa C. Newly activated T cells promote maturation of bystander dendritic cells but not IL-12 production. J. Immunol. 171 (2003) 6406-6413
41. Steinman R.M., and Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137 (1973) 1142-1162
42. + T cell responses in patients with metastatic prostate cancer. J. Immunol. 174 (2005) 3798-3807
43. Sugiura K., Kato K., Hashimoto F., Jin T., Amoh Y., Yamamoto Y., Morita H., Okumura K., and Ikehara S. Induction of donor-specific T cell energy by portal venous injection of allogeneic cells. Immunobiology 197 (1997) 460-477
44. Sugiura K., Nishikawa M., Ishiguro K., Tajima T., Inaba M., Torii R., Hatoya S., Wijewardana V., Kumagai D., Tamada H., Sawada T., Ikehara S., and Inaba T. Effect of ovarian hormones on periodical changes in immune resistance associated with estrous cycle in the beagle bitch. Immunobiology 209 (2004) 619-627
45. Vail D.M., and MacEwen E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest. 18 (2000) 781-792
46. Weber M., Lange C., Gunther W., Franz M., Kremmer E., and Kolb H.J. Minor histocompatibility antigens on canine hemopoietic progenitor cells. J. Immunol. 170 (2003) 5861-5868
47. Yanagawa Y., and Onoe K. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities. Blood 15 (2003) 4923-4929
48. Yoshida H., Momoi Y., Taga N., Ide K., Yamazoe K., Iwasaki T., and Kudo T. Generation of canine dendritic cells from peripheral blood mononuclear cells. J. Vet. Med. Sci. 65 (2003) 663-669
49. + dendritic cells. Proc. Natl. Acad. Sci. 93 (1996) 2588-2592